Legal Representation
Attorney
Ajay A. Jagtiani
USPTO Deadlines
Next Deadline
977 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-03-22)
Due Date
March 22, 2028
Grace Period Ends
September 22, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
38 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 21, 2025 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Aug 14, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Aug 14, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Aug 14, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Aug 14, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Aug 14, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Mar 22, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Feb 15, 2022 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Feb 12, 2022 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Dec 16, 2021 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Dec 16, 2021 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Nov 18, 2021 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Nov 18, 2021 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Jun 19, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 17, 2021 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jun 17, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 17, 2021 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Apr 7, 2021 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Dec 29, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Nov 3, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Nov 3, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 14, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 27, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 27, 2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Sep 27, 2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 27, 2020 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 27, 2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Sep 24, 2020 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Sep 21, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 21, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 21, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 19, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 19, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 19, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 18, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 20, 2020 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Feb 19, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 17, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations, biological preparations, and gene therapy products for medical or pharmaceutical purposes, namely, gene therapies, viral vectors, DNA plasmids, and nucleic-acid delivery products for use in the treatment of genetic diseases and disorders
First Use Anywhere:
Aug 12, 2020
First Use in Commerce:
Oct 25, 2021
Class 040
Manufacturing services for others in the field of pharmaceuticals, biopharmaceuticals, health care products and medical products; treatment of materials, namely, pharmaceutical and chemical products and their components used in the manufacture of pharmaceuticals and biopharmaceuticals; manufacture of pharmaceuticals and biopharmaceuticals to order and/or specification of others; contract manufacturing of pharmaceuticals, cells and gene therapy reagents
First Use Anywhere:
Aug 12, 2020
First Use in Commerce:
Aug 12, 2020
Class 042
Product development for others relating to pharmaceuticals, biopharmaceuticals, health care products and medical products; scientific and technological consulting services in the pharmaceutical industry, and research and design relating thereto; industrial analysis in the nature of product testing and research and industrial research in the field of pharmaceuticals, biopharmaceuticals, health care products and medical products; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical research and development; product development consultation; product research services, namely, providing analytical testing, biosafety testing, reporting and laboratory services for others; scientific and technical product development consulting and research services for the pharmaceutical industry; custom design and development of chemical reagents and biochemical assays
First Use Anywhere:
Aug 12, 2020
First Use in Commerce:
Aug 12, 2020
Additional Information
Design Mark
The mark consists of the word "ANDELYN" in stylized font, with a honeycomb pattern beneath the right side of the word. The words "BIOSCIENCES RELIABLY EXPERT. PURPOSEFULLY DRIVEN". appear beneath the left side of "ANDELYN".
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
040
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOSCIENCES"